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Summary
The trace element copper (Cu) is a cofactor for biochemical functions ranging fromenergy generation to iron (Fe) acquisition,
angiogenesis, and free radical detoxification.While Cu is essential for life, themolecules thatmediate dietaryCu uptake have
not been identified. Ctr1 is a homotrimeric protein, conserved from yeast to humans, that transports Cu across the plasma
membrane with high affinity and specificity. Here we describe the generation of intestinal epithelial cell-specific Ctr1 knock-
outmice. Thesemice exhibit striking neonatal defects in Cu accumulation in peripheral tissues, hepatic Fe overload, cardiac
hypertrophy, and severe growth and viability defects. Consistent with an intestinal Cu absorption block, the growth and
viability defects can be partially rescued by a single postnatal Cu administration, indicative of a critical neonatal metabolic
requirement for Cu that is provided by intestinal Ctr1. These studies identify Ctr1 as the major factor driving intestinal Cu
absorption in mammals.Introduction
The ability of copper (Cu) to undergo changes in redox state
has been harnessed by aerobic organisms to drive enzyme
catalysis, signal transduction, and protein structure. Indeed,
Cu is an essential nutrient for all eukaryotic organisms due to
its function with enzymes that participate in a broad range
of critical processes that include respiration, neuropeptide
maturation, protection from oxidative stress, neurotransmitter
biogenesis, pigmentation, angiogenesis, iron (Fe) absorption,
connective tissue maturation, and a host of other key biological
functions (Linder, 1991; Pen˜a et al., 1999; Puig and Thiele,
2002). Consistent with the importance of these Cu-dependent
processes, genetically programmed or dietarily induced Cu
deficiency in mammals results in impaired motor function, re-
duced aortic elasticity, neutropenia, cardiac hypertrophy,
anemia, severe cognitive disorders, growth defects, and other
pathological states (Linder, 1991; Prohaska, 2000; Shim
and Harris, 2003). In general, younger animals are more suscep-
tible to Cu deficiency as compared to mature animals, but
the precise mechanisms for this differential sensitivity are not
well understood (Uauy et al., 1998; Prohaska and Brokate,
2002).
Currently much is known with respect to the proteins that
carry out Cu homeostasis at the cellular level and their regulation
(reviewed in Pen˜a et al., 1999; Puig and Thiele, 2002). In organ-
isms from yeast to humans, a conserved homotrimeric plasma
membrane protein, Ctr1, mediates Cu import with high affinity
and specificity (Lee et al., 2002a; Puig et al., 2002; Eisses
et al., 2005). After import, Cu is targeted to proteins or organelles
by specific Cu chaperone proteins that function in the delivery of
Cu to mitochondrial cytochrome oxidase (via Cox17), to Cu,Zn
superoxide dismutase (via CCS), and (via Atox1) to the cytosolic
Cu binding domain of the P-type Cu-transporting ATPases,
ATP7A or ATP7B, which deliver Cu to the lumen of a late secre-CELL METABOLISM 4, 235–244, SEPTEMBER 2006 ª2006 ELSEVIERtory compartment where it is loaded onto Cu-requiring proteins
(Huffman and O’Halloran, 2001; Lutsenko and Petris, 2002; Luk
et al., 2003). One such protein is hephaestin (Heph), a transmem-
brane copper-dependent ferroxidase that functions, in addition
to ferroportin, to move iron (Fe) across the basolateral mem-
brane of intestinal epithelial cells into the circulation. In mouse
models, defects in hephaestin function underlie sex-linked ane-
mia (Vulpe et al., 1999). In the bloodstream another multicopper
ferroxidase, ceruloplasmin (Cp), oxidizes Fe(II) to Fe(III), thereby
facilitating the loading of Fe(III) onto transferrin for delivery
to peripheral organs via transferrin receptor-mediated endocy-
tosis (Andrews, 2000; Hellman and Gitlin, 2002; Kaplan, 2002).
Aceruloplasminemic patients or Cp knockout mice suffer from
progressive Fe accumulation (Harris et al., 1995; Waggoner
et al., 1999; Hellman and Gitlin, 2002). As such, Heph and Cp
constitute critical biochemical links between Cu availability
and normal Fe acquisition and distribution (Hellman and Gitlin,
2002; Fox, 2003). Cu is delivered across the basolateral mem-
brane of intestinal epithelial cells via the trafficking of ATP7A
to the basolateral membrane when Cu levels are elevated, pro-
viding a regulated means of moving Cu from the point of apical
absorption to the site of exit for peripheral distribution (Llanos
and Mercer, 2002). Patients harboring a nonfunctional ATP7A
gene inherit Menkes kinky hair disease, a lethal childhood dis-
ease of Cu overload in intestinal epithelial cells and deficiency
in the periphery (Lutsenko and Petris, 2002; Llanos and Mercer,
2002).
Previous studies suggest that Cu is absorbed in the small in-
testine via a carrier-mediated, saturable process (Linder, 1991).
Furthermore, the efficiency of Cu uptake has been demon-
strated to be modulated by dietary Cu status; when dietary Cu
status is low, Cu is absorbed more efficiently than when Cu
status is high (Turnlund, 1998). These studies suggest the pres-
ence of one or more specific molecules that carry out intestinal
Cu absorption and the possibility that expression, activity, orINC. DOI 10.1016/j.cmet.2006.08.009 235
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Cu status. At present the identity of proteins that mediate intes-
tinal epithelial Cu transport is unknown. While studies suggest
that the broad spectrum metal transporter DMT1 transports
Cu(I) into cultured polarized epithelial cells (Ferruzza et al.,
2000; Arredondo et al., 2003), DMT1 has specificity for divalent
metal ions (Gunshin et al., 1997).
Mammalian cell culture studies strongly support a role for Ctr1
in cellular Cu uptake (Lee et al., 2002a; Puig et al., 2002; Eisses
et al., 2005). Ctr1 exhibits a Km for Cu ofw1 mM, shows exquisite
specificity for Cu, and transports Cu in an ATP-independent
manner via conserved methionine residues located in the hydro-
philic amino terminus and within the second of three transmem-
brane domains (Puig et al., 2002). Biochemical, genetic, and re-
cent two-dimensional electron microscopy studies indicate that
Ctr1 forms a pore for metal movement across membranes via
the formation of a homotrimer (Lee et al., 2002a; Puig et al.,
2002; Aller and Unger, 2006). Recent reports suggest that mam-
malian Ctr1 is constitutively recycling from an endosomal com-
partment to the plasma membrane and is stimulated to undergo
Cu-specific and rapid clathrin-dependent endocytosis at Cu
concentrations near the Km for transport (Petris et al., 2003;
Guo et al., 2004). While Ctr1 is localized to the plasma mem-
brane in many cultured cell lines, Ctr1 also localizes to intra-
cellular vesicular compartments in other cells, perhaps reflect-
ing distinct differences in Cu status or the endocytic
machinery (Klomp et al., 2002). In response to high Cu concen-
trations, Ctr1 endocytosis leads to degradation, potentially
providing a rapid and Cu-specific mechanism to regulate Ctr1-
mediated high-affinity Cu uptake (Petris et al., 2003; Guo
et al., 2004).
Little is known about the physiological role of Ctr1 in dietary
Cu acquisition in mammals and in Cu delivery to peripheral
tissues. Interestingly, Ctr1+/2 mice exhibit no obvious growth
or developmental abnormalities. However, these mice do ex-
hibit tissue-specific reductions in Cu accumulation and in Cu-
dependent enzyme activities in brain and spleen (Lee et al.,
2001; Kuo et al., 2001). Moreover, Ctr12/2 mice are embryonic
lethal, with embryos exhibiting poor growth rates and defects
in development of neural ectoderm and mesoderm (Lee et al.,
2001; Kuo et al., 2001). Ctr12/2 fibroblasts exhibit an w70%
reduction in Cu uptake and accumulation compared to wild-
type cells but also express a biochemically distinct Cu uptake
activity of a lower affinity (Kmw10 mM) that appears to transport
Cu(II), rather than Cu(I) (Lee et al., 2002b).
To determine whether Ctr1 might function in intestinal Cu
acquisition, we generated a mouse model in which the Ctr1 lo-
cus is excised specifically and efficiently in intestinal epithelial
cells. These mice exhibit striking early postnatal defects in
growth, peripheral Cu accumulation, and the activities of Cu-
dependent enzymes; a profound hepatic Fe hyperaccumulation;
pronounced cardiac hypertrophy; and other pathologies.
Surprisingly, these animals can be rescued with a single Cu
administration to the periphery, indicating a critical requirement
for Ctr1-mediated intestinal Cu absorption in neonates. More-
over, intestinal epithelial cells from Ctr1 intestinal epithelial
knockout mice demonstrated an unexpected and dramatic
hyperaccumulation of Cu that is not biologically available,
suggesting a critical role for Ctr1 in Cu metabolism both
at the plasma membrane and potentially in an intracellular
compartment.236Results
Generation of an intestinal epithelial Ctr1 knockout
mouse model
To ascertain if Ctr1 may function in intestinal Cu absorption,
immunohistochemistry was carried out on mouse intestinal
duodenal cross-sections (Figure 1A). While no specific signal
was detected in the absence of antibody (data not shown), affin-
ity-purified anti-Ctr1 antibody showed a clear staining of the
apical membrane of intestinal epithelial cells, with an increase
in expression from the crypt to the tip of the villus. Other duode-
nal immunohistochemical analyses of Ctr1 (for example, see
Figure 1E), and a recent report (Kuo et al., 2006), indicate both
apical membrane staining and Ctr1 localization to intracellular
compartments that may be similar to the endosomal compart-
ments previously described (Klomp et al., 2002; Petris et al.,
2003).
Ctr1 is at least partially localized to the apical membrane of
mouse intestinal epithelial cells and therefore could function in
intestinal dietary Cu uptake. Because a systemic Ctr1 knockout
is embryonic lethal (Lee et al., 2001; Kuo et al., 2001), we gener-
ated a conditional knockout Ctr1 allele by flanking the entire
coding region with loxP recombination sites from the bacterio-
phage P1 (Sauer, 1998; Nagy, 2000), by homologous recombi-
nation in mouse embryonic stem (ES) cells (Nagy et al., 1993).
ES cells heterozygous for this allele (Figure 1B) were used for
germline transmission manipulations to create a mouse homo-
zygous for theCtr1 allele flanked by loxP sites, hereafter referred
to as Ctr1flox/flox (Figure S1 in the Supplemental Data available
with this article online). The homozygous Ctr1 floxed mice
appeared in litters at the expected Mendelian frequency and ex-
hibited no obvious growth or developmental defects, and Cu
concentrations in brain, heart, liver, kidney, spleen, serum,
and isolated intestinal epithelial cells were indistinguishable
from wild-type mice (Table S1).
To generate mice specifically depleted for Ctr1 in intestinal
epithelial cells, the Ctr1flox/flox mice were crossed with a trans-
genic mouse expressing the nuclear-targeted bacteriophage
P1 Cre recombinase driven from a 12.4 kb Villin promoter. Pre-
vious studies demonstrated that these mice express Cre en-
zyme specifically in intestinal enterocytes with increasing levels
from the crypt to the tip of the villus along the entire intestinal
tract (Madison et al., 2002). Villin-Cre; Ctr1flox/flox mice were ob-
tained at the expected Mendelian ratio, suggesting the absence
of a growth or developmental selection against the inheritance
of these alleles. To ascertain the Ctr1 allele status, tissues
from postnatal day 14 (P14) were subjected to PCR genotyping.
As shown in Figure 1C, Ctr1flox/flox mice lacking Cre recombi-
nase exhibited no Ctr1 excision in any tissue. However,
Ctr1flox/flox mice harboring the Villin-Cre transgene had excised
Ctr1 from intestinal epithelial cells (IEC) with high efficiency,
with no detectable Ctr1 excision in brain, heart, liver, kidney,
or spleen. These mice are hereafter referred to as Ctr1int/int
mice, to signify Ctr1 excision specifically in intestinal epithelial
cells. Immunoblotting of membrane extracts from these same
tissues revealed undetectable levels of Ctr1 in intestinal epithe-
lial cells of Ctr1int/int mice, whereas the levels in control mice
were readily detectable and not reduced in other tissues relative
to control mice (Figure 1D). Ctr1 levels may be slightly elevated
in heart and liver tissue fromCtr1int/int mice, perhaps due to a pe-
ripheral Cu deficiency (see below) that minimizes Cu-inducedCELL METABOLISM : SEPTEMBER 2006
Intestinal Ctr1 in Cu metabolismFigure 1. Conditional deletion of Ctr1 in intestinal
epithelia
A) Immunohistochemistry of wild-type (Ctr1+/+)
mouse duodenum probed with anti-Ctr1 (1:100 dilu-
tion). Immunopositive staining (brown) represents
the presence of Ctr1 on the apical membrane of
the intestinal epithelium.
B) Targeting strategy used for conditional deletion of
Ctr1. The Ctr1 structural gene (gray boxes) was
flanked by loxP sites (black triangles) followed by
the PGKneo gene cassette (black box) with an addi-
tional loxP site. The PGKneo gene was removed by
crossbreeding with EIIaCre mice, and mice having
the desired allele of Ctr1 flanked by loxP (floxed)
were obtained. The Ctr1-deleted allele (deleted)
was obtained by crossbreeding with Villin-Cre
mice. The locations of the PCR primer (P1, P2, and
P3) binding sites used to diagnose Cre-mediated
deletion are shown as open arrows.
C) PCR analysis of tissue DNA from Ctr1flox/flox and
intestinal Ctr1 knockout (Ctr1int/int) mice at postnatal
day (P) 14. The PCR product fromCtr1floxed is 242 bp,
whereas the product from Ctr1int/int is 281 bp. I, iso-
lated intestinal epithelial cells; B, brain; H, heart;
L, liver; K, kidney; S, spleen.
D) Immunoblot analysis of tissue Ctr1 protein. Blots
were probed with anti-Ctr1 antibody (1:1000 dilu-
tion). flox, Ctr1flox/flox; int, Ctr1int/int; IEC, isolated in-
testinal epithelial cells. The Ctr1 homodimer (double
closed circle) and monomer form (single closed cir-
cle) were detected (left panel). The gel was stained
with Coomassie blue (right panel).
E) Immunohistochemistry of Ctr1flox/flox and Ctr1int/int
mouse duodenum with anti-Ctr1 antibody (1:100
dilution).endocytosis and degradation that has been observed in some
cultured cell lines (Klomp et al., 2002; Petris et al., 2003). It is no-
table that, while the steady-state levels of Ctr1 mRNA and pro-
tein are abundant in kidney tissue from mature mice (Lee et al.,
2000), Ctr1 protein levels are very low in kidney from these 2-
week-old mice. Immunohistochemistry of duodenal villus
cross-sections with anti-Ctr1 antibody showed robust staining
of Ctr1 on both the apical membrane and on internal compart-
ments that may correspond to previously identified endosomes
(Petris et al., 2003; Guo et al., 2004) from wild-type animals, but
almost undetectable Ctr1 levels in IEC of Ctr1int/int mice
(Figure 1E). Taken together, these data demonstrate the gener-
ation of a highly efficient and highly specific intestinal epithelial
Ctr1 knockout mouse model.
Ctr1int/int mice exhibit growth and peripheral Cu
absorption defects
While Ctr1int/int mice were born at the expected frequency and
exhibited normal growth rate and mass for the first 6–8 days
postpartum, poor growth and lethality occurred beginningCELL METABOLISM : SEPTEMBER 2006approximately 10 days after birth (Figures 2A and 2B). While
the majority of Ctr1int/int mice died with severe weight loss (as
shown in Figure 2C at day P14, a representative Ctr1flox/flox
mouse had a mass of approximately 9 grams, while a Ctr1int/int
mouse weighed less than 4 grams), weight loss was less severe
in some mice. Furthermore, while there was nearly 100% lethal-
ity for Ctr1int/int mice by approximately 3 weeks postpartum, 3 of
approximately 110 Ctr1int/int mice were asymptomatic. Further
analysis of these mice demonstrated very low expression of
Cre recombinase and levels of intestinal epithelial Ctr1 protein
that were indistinguishable from control mice (data not shown).
The Ctr1int/int mice also displayed hypopigmentation, skin laxity,
ataxia, and brittle, kinky whiskers, reminiscent of the human
Cu homeostasis disease known as Menkes kinky hair disease
(Lutsenko and Petris, 2002; Llanos and Mercer, 2002) (Figures
2C and 2D).
Since Ctr1int/int mice exhibit outward phenotypes consistent
with deficits in the activities of Cu-dependent enzymes, the
steady-state levels of Cu accumulated in several peripheral
tissues were evaluated by ICP-MS and compared to those of237
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peripheral tissues evaluated was significantly reduced com-
pared to control littermates, with severe reductions in liver
(w5%), heart (w18%), and brain (w20%) as compared to con-
trol animals. Spleen and serum Cu levels were under 40% the
levels of control mice. Interestingly, Cu levels from Ctr1int/int kid-
ney were reproducibly 70% or more that of the kidney from con-
trol animals. Furthermore, while tissue Zn levels were not signif-
icantly altered as compared to control mice (Figure 3B), liver Fe
levels were strongly elevated more than 4-fold over those of
control mice, with smaller changes in other tissues (Figure 3C).
Consistent with Fe hyperaccumulation, IEC and liver but not
kidney from Ctr1int/int mice also exhibited dramatically elevated
levels of the Fe storage protein ferritin as compared to control
littermates (Figure 3D). To ascertain which liver cell types accu-
mulate Fe in Ctr1int/int mice, liver sections were stained with
Perl’s Prussian blue and visualized by light microscopy. While
no significant Fe deposits were detected by this method in con-
trol liver samples, liver from Ctr1int/int mice accumulated Fe
predominantly in Kupffer cells (Figure 3E).
The severe growth defects ofCtr1int/int mice, coupled with sig-
nificant reductions in Cu accumulation in peripheral tissues and
gross hepatic Fe accumulation, would predict deficits in cellular
enzymatic activities or regulatory events that are dependent on
Cu. Indeed, mitochondrial cytochrome oxidase activity was
severely decreased in total brain, heart, and liver lysates of
Ctr1int/int mice as compared to control littermates (Figure 4A);
these same tissues exhibited the most profound Cu deficits.
Moreover, in line with Cu accumulation measurements (Fig-
ure 3A), no significant change in cytochrome oxidase activity
was observed in kidney. Consistent with the hypopigmentation
phenotype of Ctr1int/int mice, skin extracts from these mice ex-
hibit reduced levels of tyrosinase activity (Figure 4B).
Figure 2. Growth and survival phenotypes of Ctr1int/int mice
A and B) The growth curve (A) (mean 6 SD) and the survival ratio (B) of mutant
and control mice. Blue, Ctr1+/+, Ctr1flox/+, and Ctr1flox/flox (n = 57); green, Ctr1int/+
(n = 47); red, Ctr1int/int (n = 26). The expected life span of Ctr1int/int was 16 6 4
days (mean 6 SD) (n = 22).
C) Mouse siblings at P14. Left, Ctr1int/int; right, Ctr1flox/flox.
D) Ctr1int/int mice exhibit kinky whiskers.238A well-characterized Cu-dependent enzyme, Cu,Zn superox-
ide dismutase (SOD1), is Cu metallated in yeast and mammals
via the action of the CCS Cu chaperone (Rae et al., 1999;
Wong et al., 2000; Schmidt et al., 2000). While previous studies
have demonstrated that Cu-deficient animal models exhibit
clear deficiencies in SOD1 activity (Prohaska et al., 2003), recent
studies have demonstrated that steady-state CCS levels are in-
versely proportional to intracellular Cu availability due to 26S
proteasome-dependent degradation in a highly specific manner
(Bertinato and L’Abbe´, 2003; West and Prohaska, 2004; Car-
uano-Yzermans et al., 2006). We evaluated steady-state CCS
Figure 3. Peripheral Cu hypoaccumulation and hepatic Fe hyperaccumulation in
Ctr1int/int mice
A–C) Relative Cu (A), Zn (B), and Fe (C) concentrations were measured in each tis-
sue ofCtr1int/int (n = 6) compared to control (Ctr1flox/+ andCtr1flox/flox) (n = 6) mice by
ICP-MS. Data are represented as the percent of metal concentration (mg metal/mg
tissue wet weight) in mutant mouse tissues compared to those of control (aver-
age + SD). B, brain; H, heart; L, liver; K, kidney; Sp, spleen; M, skeletal muscle;
Se, serum. Dashed lines represent 100% of each metal in control mouse tissues.
D) Immunoblot of ferritin from IEC, liver, and kidney protein extracts derived from
Ctr1flox/flox and Ctr1int/int mice. The positions of ferritin and the actin loading control
are indicated with arrowheads.
E) Perl’s staining of liver sections from Ctr1flox/flox and Ctr1int/int mice. The left
(Ctr1flox/flox) and middle (Ctr1int/int) panels show lower magnification of liver sec-
tions. Iron deposits were observed in Ctr1int/int liver as blue spots (arrowheads).
The right panel shows a higher magnification of a Ctr1int/int liver section. Iron
deposits were observed in Kupffer cells (arrowheads). Cytosol and nuclei are
counterstained with pararosaniline.CELL METABOLISM : SEPTEMBER 2006
Intestinal Ctr1 in Cu metabolismlevels as an indicator of endogenous bioavailable Cu levels and
compared CCS levels in several tissues in control and Ctr1int/int
mice. As shown by immunoblotting with anti-CCS antiserum in
Figure 4C, the CCS steady-state levels increased significantly
in each tissue from the Ctr1int/int mice as compared to control lit-
termates. The increase in CCS steady-state levels was also ob-
served in kidney, indicating that even modest perturbation of
steady-state Cu accumulation alters CCS proteolysis. This sug-
gests that changes in CCS levels may be a more sensitive reflec-
tion of bioavailable Cu levels than the analysis of Cu-dependent
enzymes. Due to the structural similarity between SOD1 and the
central domain of mammalian CCS (Lamb et al., 2000; Huffman
and O’Halloran, 2001), the antibody used for immunoblotting
shown in Figure 4C also crossreacts with SOD1. While the liver
sample shows elevated SOD1 levels in control liver samples rel-
ative to the Ctr1int/int mouse, this is not reproducible in other ex-
periments, and this particular lane was overloaded.
The multicopper ferroxidase ceruloplasmin is a serum glyco-
protein that is synthesized and matured in the liver and secreted
in the serum, where it functions in Fe(III) loading onto transferrin
for distribution to peripheral tissues (Andrews, 2000; Hellman
and Gitlin, 2002; Kaplan, 2002). Furthermore, a recent report
suggests that ceruloplasmin also functions in Fe efflux from in-
testinal enterocytes (Cherukuri et al., 2005). While Cu deficiency
in cell culture and in vivo does not alter ceruloplasmin protein
synthesis, these conditions are known to severely compromise
the incorporation of seven Cu atoms into the protein as it tra-
verses the secretory pathway (Sato and Gitlin, 1991; Hellman
et al., 2002). Because of the severe hepatic Cu depletion in
Ctr1int/int mice, we evaluated ceruloplasmin metallation state
Figure 4. Ctr1int/int mice exhibit biochemical signatures of Cu deficiency
A) Cytochrome c oxidase (CCO) activity. Tissue extracts from three control
(Ctr1flox/+ and Ctr1flox/flox) and three Ctr1int/int mice were used to measure CCO
activity. Data are represented as mU/mg protein (mean + SD) (n = 3). B, brain;
H, heart; L, liver; K, kidney. Dark bars represent CCO activity from control mice,
and light bars represent CCO activity from Ctr1int/int mice.
B) Skin tyrosinase activities. The arrowhead indicates tyrosinase activity. The gel
was stained with CBB to control for protein loading (lower panel). flox, Ctr1flox/flox;
int, Ctr1int/int.
C) Immunoblot for copper chaperone for superoxide dismutase (CCS) steady-
state levels. The membrane was probed with anti-CCS antibody at 1:200 dilution.
Cu,Zn-superoxide dismutase (SOD1) is shown as a loading control. B, brain;
H, heart; L, liver; K, kidney. flox, Ctr1flox/flox; int, Ctr1int/int.
D) Ceruloplasmin (Cp) Cu metallation assays. One microliter serum from three
Ctr1flox/flox and three Ctr1int/int mice was subjected to nonreducing SDS-PAGE
and immunoblotting with anti-human Cp antibody. flox, Ctr1flox/flox; int, Ctr1int/int.
Arrows indicate the positions of the apo-Cp and holo-Cp polypeptides.CELL METABOLISM : SEPTEMBER 2006using nonreducing SDS-PAGE and immunoblotting. As shown
in Figure 4D, while serum from control littermates harbors pre-
dominantly holo-ceruloplasmin, with low levels of apo-protein,
serum from Ctr1int/int mice resolves almost exclusively apo-
ceruloplasmin, with holo-ceruloplasmin detectable only upon
overexposure of the immunoblot (data not shown). Taken
together, tissue steady-state Cu accumulation measurements,
Cu-dependent enzyme activity deficits, increased CCS levels,
and decreased ceruloplasmin Cu loading in Ctr1int/int mice as
compared to the control littermates demonstrate that Ctr1 plays
a highly significant role in mammalian intestinal Cu absorption.
Cardiac hypertrophy associated with Ctr1int/int mice
Animal models of dietary Cu deficiency demonstrate clear
defects in angiogenesis, impaired aortic elasticity, and cardiac
hypertrophy (Linder, 1991; Uauy et al., 1998; Prohaska and Bro-
kate, 2002; Elsherif et al., 2003). This latter condition is thought
to be accompanied by mitochondrial volume increases that ulti-
mately lead to large vacuolar mitochondrial structures in which
cristae have lost the typical parallel array (Elsherif et al., 2004).
As shown in Figure 2C, P14 Ctr1int/int mice are profoundly
smaller than control littermates. Accordingly, the mass ratio
(wet weight/total body mass) of several tissues including spleen
was significantly smaller for the mutant mouse (Figure 5A),
whereas there was no significant difference in the mass ratio
of the kidney comparing six control and six mutant mice. Inter-
estingly, the heart mass ratio was significantly increased in
Ctr1int/int mice compared to control littermates (n = 10), where
there was an averagew20% increase in heart mass relative to
total body mass. Hematoxylin and eosin staining of heart sec-
tions revealed abundant large vacuoles in cardiac tissue from
the Ctr1int/int mice, but not in cardiac tissue from control litter-
mates (Figure 5B). Electron microscopic evaluation of thin sec-
tions of fixed cardiac tissue from these mice showed a regular
array of mitochondria-packed cells in control tissue, whereas
Ctr1int/int cardiac tissue exhibited swollen, pale mitochondria
and features consistent with the vacuoles being derived from
swollen mitochondria harboring disordered cristae (Figures 5C
and 5D). Taken together, these studies demonstrate that the pe-
ripheral Cu deficiency due to loss of intestinal epithelial cell Ctr1
leads to cardiac hypertrophy within 2 weeks after birth.
Ctr1int/int intestinal epithelial cells hyperaccumulate Cu
Our data support the notion that, normally, Ctr1 transports die-
tary Cu across the apical membrane, whereupon it is utilized
intracellularly and pumped across the basolateral membrane,
to the portal circulation, via the Cu-transporting ATPase
ATP7A. We analyzed the Cu content of purified intestinal epithe-
lial cells from Ctr1int/int mice and control littermates. Unexpect-
edly, purified IEC from Ctr1int/int mice accumulated over eight
times the levels of Cu as compared to IEC from control litter-
mates (Figure 6A). Fe or Zn levels were not significantly elevated
in these cells compared to control IEC. To explore whether these
highly elevated Cu levels are available to drive Cu-dependent
enzymatic and regulatory events, several markers of intracellular
bioavailable Cu were analyzed. As shown in Figure 6B, steady-
state levels of CCS are strongly elevated in Ctr1int/int IEC com-
pared to control cells, with no change in steady-state SOD1 pro-
tein. Recent studies have also demonstrated that hephaestin,
a Cu-dependent ferroxidase localized to the basolateral mem-
brane of IEC and expressed in kidney that facilitates Fe export,239
A R T I C L Eis regulated by Cu levels in a direction opposite to that of CCS
(Nittis and Gitlin, 2004). Steady-state hephaestin protein levels
are elevated by Cu and reduced in Cu-deficient cells. As shown
in Figure 6C, IEC from Ctr1int/int mice have reduced hephaestin
levels relative to that from control mice. Furthermore, levels of
Figure 5. Ctr1int/int mice exhibit cardiac hypertrophy 2 weeks postpartum
A) The organ/body mass ratio of mutant (Ctr1int/int) mice is compared to that of
control (Ctr1flox/flox) mice (mean + SD) (n = 10) (p < 0.01).
B) Ctr1int/int mouse cardiac tissue histology. Mouse heart sections were stained
with hematoxylin and eosin. Left panel: Ctr1flox/flox; right panel: Ctr1int/int. Vacuole
structures are indicated with arrowheads.
C) Electron microscopy of cardiac tissue. Left panel (Ctr1flox/flox) and right panel
(Ctr1int/int) are 30003 magnifications of heart thin sections. The contrast of those
two pictures is different to show the structural details of mitochondria.
D) Cardiac thin section electron micrographs from Ctr1int/int mice showing vacu-
oles containing cristae structures.240hephaestin were unchanged in kidney, a tissue in which
steady-state Cu levels did not change dramatically. The oppos-
ing regulation of CCS and hephaestin observed in Ctr1int/int mice
is consistent with a reduction in Cu that is available to signal the
proteolysis of CCS and hephaestin (Bertinato and L’Abbe´, 2003;
Nittis and Gitlin, 2004; West and Prohaska, 2004; Caruano-
Yzermans et al., 2006). To further test this notion, the levels of
cytochrome oxidase activity were measured in IEC isolated
from Ctr1int/int mice and from control littermates. As shown in
Figure 6D, cytochrome oxidase activity was reduced approxi-
mately 3-fold in Ctr1int/int IEC cells compared to control cells.
Taken together, these results demonstrate that, while intestinal
epithelial cell Ctr1 is essential for dietary acquisition of Cu for
delivery to peripheral tissues, it is also required to prevent the
hyperaccumulation of Cu in IEC in an as yet unidentified biolog-
ically unavailable pool.
Bypassing intestinal Cu absorption rescues
Ctr1int/int mice
To further test whether the growth, biochemical, and patholog-
ical phenotypes observed in Ctr1int/int mice are due to a critical
role for Ctr1 in dietary Cu absorption, we attempted to bypass
intestinal Cu absorption. Ctr1int/int or control mice at day P5 or
P6 were given an intraperitoneal (IP) injection of 10 mg/g total
body mass of CuSO4 in 10 ml of physiological saline, or saline
alone, and monitored for growth rate and survival. Control mice
were unaffected by the injection of saline or copper (Figure 7A).
Three Ctr1int/int mice injected with saline alone showed early
postnatal lethality, with or without progressive weight loss, by
postnatal day 20 (Figure 7B, open circles), similar to that ob-
served for the Ctr1int/int mice shown in Figure 2B. In contrast, all
three Ctr1int/int mice receiving a single IP copper injection dem-
onstrated neither weight loss nor early postnatal death. One or
two mice from an independent copper rescue experiment were
sacrificed for analysis of heart/body mass ratio, cardiac tissue
histology, and tissue copper levels. This preliminary analysis
suggested that the cardiac hypertrophy (heart/body mass ratio)
and vacuoles observed inCtr1int/int mice treated with saline were
partially reversed with copper treatment (data not shown). Fur-
thermore, Ctr1int/int mice injected with copper showed a trend
toward restoration of copper levels in peripheral tissues, though
these analyses are not statistically significant due to availability
of only one or two animals. Two of the copper-injected Ctr1int/int
mice described in Figure 7B are currently 5 months old and
appear outwardly asymptomatic. Interestingly, as described
for a few atypical mice for Figure 2B, one Ctr1int/int mouse in-
jected with saline demonstrated neither progressive weight
loss nor early postnatal lethality (Figure 7B). Upon evaluation
this mouse expressed low levels of Cre recombinase and normalFigure 6. Hyperaccumulation of Cu by Ctr1int/int IEC
A) Relative Cu, Fe, and Zn levels associated with
Ctr1int/int IEC compared to those of control
(Ctr1flox/flox) cells. Data are represented as percent
of control cells (mean + SD) (n = 6). Wild-type levels
are indicated with a dashed line.
B) CCS levels (with SOD1 as loading control).
C) Hephaestin levels in IEC and from kidney were
detected by immunoblotting with anti-hephaestin
antibody at 1:1000 dilution. Heph and Actin are indi-
cated with arrowheads.
D)Cytochrome c oxidase activity was assayed in IEC
as described for Figure 4 (mean + SD) (n = 3).CELL METABOLISM : SEPTEMBER 2006
Intestinal Ctr1 in Cu metabolismlevels of Ctr1 protein in IEC. Taken together, these copper reme-
diation experiments demonstrate the ability to rescue the
growth and early postnatal lethality associated with loss of intes-
tinal epithelial Ctr1. Furthermore, the experimental results
shown in this report firmly establish the importance of the Cu im-
port activity of Ctr1 in intestinal epithelial cells, rather than some
as yet unidentified Ctr1-dependent activity.
Discussion
Cu metabolism is essential to drive biochemical reactions criti-
cal for growth, development, cognition, and a host of other
key life processes. While all Cu acquisition is thought to occur
via dietary absorption in the small intestine, pivotal molecules
that mediate Cu uptake in the intestine had not been identified.
In this work we demonstrate that Ctr1 is expressed in vivo in in-
testinal epithelial cells on the apical membrane and in intracellu-
lar vesicular compartments, consistent with previous Ctr1 local-
ization studies in a range of cultured cell lines (Lee et al., 2002a;
Klomp et al., 2002). Ctr1 has previously been demonstrated to
function in metal-specific high-affinity Cu uptake while residing
on the plasma membrane of distinct mammalian and insect cell
lines (Lee et al., 2002a; Puig et al., 2002; Eisses et al., 2005).
Transfection studies expressing epitope-tagged versions of Ctr1
have shown that, while Ctr1 undergoes constitutive recycling
to and from the plasma membrane, it is rapidly endocytosed
in response to elevated Cu concentration, but not other metals
Figure 7. Rescue of Ctr1int/int mice with a single intraperitoneal Cu administration
Mice were given a single IP injection with 10 mg CuSO4/g body weight in 10 ml of
physiological saline or saline alone at P5 or P6, and mass was determined each
day. Weight (g) of control (Figure 7A) and Ctr1int/int (Figure 7B) mice administered
saline or copper was plotted against time (postnatal day). Each growth curve
corresponds to an individual mouse. Open circle, saline; closed circle, copper;
X, death.CELL METABOLISM : SEPTEMBER 2006(Petris et al., 2003). Ctr1 endocytosis is dependent on function-
ally important methionine residues that are conserved from
yeast to humans and is clathrin dependent, and Ctr1 colocalizes
in intracellular vesicles containing transferrin (Petris et al., 2003;
Guo et al., 2004). Our data localize endogenous mouse Ctr1 to
both the apical membrane and intracellular compartments of
intestinal epithelial cells and suggest that Ctr1 may cycle to
and from the plasma membrane in these cells. Further studies
will be necessary to ascertain whether Ctr1 is subject to Cu-
stimulated endocytosis in intestinal epithelial cells and if this
regulatory mechanism is responsible for the previous observa-
tion that copper loading decreased the efficiency of dietary
copper uptake (Turnlund, 1998).
An unanticipated observation from our studies was that IEC
from Ctr1int/int mice accumulate Cu, but not other metals, at
levels eight to ten times that of IEC from control animals. Given
the dramatic rise in CCS steady-state levels, the strong reduc-
tion in hephaestin protein levels and in mitochondrial cyto-
chrome oxidase activity, these observations support the notion
that the elevated Cu associated with these cells is not bioavail-
able. Attempts to strip Cu from the surface of purified intact IEC
with strong Cu chelators, or to shave bound extracellular Cu with
proteases, were unsuccessful (data not shown), suggesting the
possibility that these cells hyperaccumulate intracellular Cu in
a form or compartment where it cannot be utilized. Since Ctr1,
like DMT1, localizes to the plasma and apical membrane, as
well as intracellular vesicles (Andrews, 2000; Gunshin et al.,
2005a), these observations suggest the possibility that Ctr1
functions to transport Cu both across the plasma membrane
and from the lumen of as yet unidentified intracellular compart-
ments. Alternatively, Ctr1 could function to transport copper in
a two step process that could entail binding of Cu(I) at the cell
surface, followed by mobilization of Cu from endosomal com-
partments in which Cu may accumulate in Ctr1int/int IEC. In either
case these data clearly demonstrate a crucial role for intestinal
Ctr1 in dietary copper absorption.
Given the established preference of yeast and mammalian
Ctr1 for Cu(I) transport, these studies suggest that Cu(I) is a prin-
cipal ionic species acquired through the diet. Furthermore,
these observations would predict the expression of one or
more metalloreductases in intestinal epithelial cells that would
function in concert with Ctr1. The recent identification of DcytB
as an intestinal brush border Fe (III) reductase is one candidate
that is strongly expressed in response to Fe deficiency (McKie
et al., 2001). While mouse Dcytb systemic knockout studies
have not revealed an Fe acquisition defect, it is possible that
DcytB functions in dietary Cu acquisition (Gunshin et al.,
2005b). It is also interesting that a family of mammalian proteins
bearing structural similarity to the yeast FRE family of Fe(III)/
Cu(II) reductases has recently been identified that could func-
tionally interact with Ctr1 (Ohgami et al., 2005, 2006).
Ctr1int/int mice exhibit severe early postnatal growth and via-
bility defects, perhaps reflecting the depletion of maternal Cu
stores. Here, we demonstrated that the early postnatal viability
defect associated with Ctr1int/int mice could be partially sup-
pressed via IP Cu administration. These results are consistent
with a critical role for Ctr1 in intestinal Cu absorption, rather
than another, as yet unidentified function for Ctr1. While our
data with only a few mice suggest that this single copper admin-
istration may also partially reverse deficits in peripheral copper
accumulation and cardiac hypertrophy, it is possible that higher241
A R T I C L ECu doses or repeated Cu administration could more completely
reverse defects associated with the Ctr1int/int mouse. More ex-
tensive studies will be needed to comprehensively test this. It
is interesting that mice lacking IEC Ctr1 show such a significant
accumulation of hepatic Fe only 2 weeks after birth. Given the
requirement for Cu in ceruloplasmin-mediated Fe(III) loading
onto the transferrin receptor, and for hephaestin-facilitated Fe
efflux thought to occur in rat liver Kupffer cells (Zhang et al.,
2004), this observation further underscores the early postnatal
requirement for Cu in normal liver Fe metabolism.
Experimental procedures
Generation of Ctr int/int mice
Details on the generation of mice containing theCtr1flox allele are described in
the Supplemental Data. Ctr1flox/flox mice were crossbred with Villin-Cre mice
(Jackson Laboratory) to make Villin-Cre; Ctr1flox/+ mice. The male Villin-Cre;
Ctr1flox/+ mice were crossbred with femaleCtr1flox/flox mice, andCtr int/int mice
were obtained. Genotyping of Ctr1 was carried out by standard approaches
using PCR with the forward primer P1 (50-AATGTCCTGGTGCGTCTGAAA-30)
and the reverse primer P2 (50-GCAGTAGATAAAAGCCAAGGC-30). To detect
tissue excision of Ctr1 by Cre recombinase, PCR with three primers, P1, P2,
and P3 (50-AAAAACCACTATTCAGAGACTG-30) was performed.
Tissue and cell preparation
Tissues were dissected after perfusion with phosphate-buffered saline (pH
7.4; PBS), frozen in liquid nitrogen, and stored at280C until use. Duodenal,
liver, and cardiac tissue was fixed immediately after dissection. Intestinal ep-
ithelial cells were isolated from mesenchyme by two independent methods.
The small intestine was opened along the long axis, washed in ice-cold PBS,
and soaked in cell recovery solution (BD Biosciences, Franklin Lakes, NJ)
containing protease inhibitors at 4C overnight with gentle agitation (Per-
reault and Beaulieu, 1998). Alternatively, washed small intestine was soaked
in PBS containing 1.5 mM EDTA and protease inhibitors at 4C for 10 min
with gentle agitation (Chen et al., 2003). After incubation the mesenchyme
layer was removed, and intestinal epithelial cells were washed three times
with ice-cold PBS with protease inhibitors and recovered by centrifugation
at 200 3 g for 7 min. Detailed methods for protein extract preparation from
tissues or cells are provided in the Supplemental Experimental Procedures.
Immunological techniques
A synthetic peptide of the sequence H2N-VSIRYNSMPVPGPNGTILC-CO2H,
which corresponds to the cytosolic loop between transmembrane domains
1 and 2 of mouse and human Ctr1, was used as antigen for generation and
affinity purification of rabbit polyclonal antiserum by Bethyl Laboratories,
Inc. (Montgomery, TX).
Tissue metal measurements
Copper, iron, and zinc concentrations were measured from nitric acid-
digested tissues by inductively coupled plasma mass spectrometry (ICP-
MS) as described (Lee et al., 2001). The values were normalized by tissue
wet weight or protein concentration.
Tissue histology
After perfusion, dissection and mass determination tissues were fixed in neu-
tralized 4% paraformaldehyde in PBS at 4C overnight with gentle agitation.
After fixation, hearts were transferred into 70% ethanol, dehydrated, and em-
bedded in paraffin. Four micrometer thick sections were made and stained
with hematoxylin and eosin. For electron microscopy, heart tissue was
minced into approximately 1 mm square cubes in 3% glutaraldehyde imme-
diately after dissection and incubated in the same solution at 4C overnight.
Sectioning, staining, microscopy, and image capture were carried out via the
Department of Pathology, Duke University Medical Center (Durham, NC).
Perl’s Prussian blue staining was carried out on perfused livers that were
fixed in neutralized 4% paraformaldehyde in PBS at 4C overnight with gentle
agitation. After fixation livers were transferred to 70% ethanol, dehydrated,
and embedded in paraffin. Six micrometer sections were stained with the
Iron Stain Kit (Sigma, St. Louis, MO).242Enzyme assays
Tissues were homogenized in five to ten times volume of 50 mM phosphate
buffer (pH 6.8) containing 0.5% Tween 80 in 1.5 ml tubes and incubated
on ice for 10 min. The homogenates were centrifuged at 16,000 3 g for
20 min at 4C. Protein concentrations were measured by the BioRad Protein
DC Assay kit (BioRad) with bovine serum albumin as a standard, and cyto-
chrome oxidase activity was measured using a Cytochrome c Oxidase Assay
Kit (Sigma). For tyrosinase assays, mouse skin biopsies were minced;
homogenized in 62.5 mM Tris-HCl (pH 6.8), 2% SDS, 1 mM ascorbate,
1 mM BCS, and protease inhibitors on ice; and incubated on ice for 1 hr.
The homogenate was centrifuged at 5000 3 g for 5 min at 4C, and the
supernatant was further centrifuged at 16,000 3 g for 20 min. The super-
natant was subjected to protein assays, 60 mg of skin extract was subjected
to nonreducing SDS-PAGE, and tyrosinase activity was measured by in-gel
colorimetric assays as described (Lee et al., 2002b).
Copper supplementation
Ctr1int/int andCtr1flox/flox (P5 or P6) mice were weighed and administered cop-
per or vehicle. Ten micrograms of copper sulfate per gram of body weight in
10 ml of 0.9% sodium chloride was injected into the IP cavity using a 10 ml
syringe (Hamilton 80366) (Hamilton, Reno, NV). For the vehicle control,
10 ml of 0.9% sodium chloride was administered in the same manner.
Body weight was monitored each day. At P14, mice from each group were
sacrificed, and cardiac tissue histology, metal levels, and ceruloplasmin Cu
loading were analyzed as described above.
Supplemental data
Supplemental Data include Supplemental Experimental Procedures, one
supplemental table, and one supplemental figure and can be found with
this article online at http://www.cellmetabolism.org/cgi/content/full/4/3/
235/DC1/.
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